VEGFA and wet macular degeneration: Pharmacodynamic tolerance to anti-VEGFA therapy in wet AMD patients may result from the elevated expression of VEGFA and its receptors, changes in signal transduction, or a shift of the stimulus for CNV growth toward other growth factors [45].